CHRISTINA SUOZZO: Open Payments
NPI 1184824278 · PATCHOGUE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 27 payments from 8 companies in 2025. Trend: 2023 $1,584 · 2024 $1,473 · 2025 $1,393
Food & beverage: $1,393
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $270 |
| Neurocrine BioSciences, Inc. | 2 | $267 |
| Otsuka America Pharmaceutical, Inc. | 2 | $250 |
| Lundbeck LLC | 13 | $235 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $117 |
| Alkermes, Inc. | 1 | $117 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: REXULTI, Auvelity, INGREZZA, CAPLYTA, COBENFY, LYBALVI, FANAPT.
Industry payments across NY — which companies pay providers there.
